Captrust Financial Advisors Tg Therapeutics, Inc. Transaction History

Captrust Financial Advisors

$33 Billion
Q3 2024

A detailed history of Captrust Financial Advisors transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Captrust Financial Advisors holds 30,327 shares of TGTX stock, worth $978,349. This represents 0.0% of its overall portfolio holdings.

Number of Shares

30,327

Previous 25,048 21.08%

Holding current value

$978,349

Previous $445,000 59.33%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$17.21 - $25.28 $90,851 - $133,453	5,279 Added 21.08%	30,327 $709,000
Q2 2024 Aug 14, 2024	BUY	$13.32 - $19.19 $4,675 - $6,735	351 Added 1.42%	25,048 $445,000
Q1 2024 May 15, 2024	SELL	$13.02 - $21.3 $73,576 - $120,366	-5,651 Reduced 18.62%	24,697 $375,000
Q4 2023 Feb 14, 2024	BUY	$6.68 - $18.81 $37,327 - $105,110	5,588 Added 22.57%	30,348 $518,000
Q3 2023 Nov 14, 2023	SELL	$8.36 - $26.5 $14,897 - $47,223	-1,782 Reduced 6.71%	24,760 $206,000
Q2 2023 Aug 14, 2023	BUY	$15.48 - $35.0 $9,736 - $22,015	629 Added 2.43%	26,542 $659,000
Q1 2023 May 15, 2023	BUY	$10.23 - $19.34 $29,196 - $55,196	2,854 Added 12.38%	25,913 $389,000
Q4 2022 Feb 15, 2023	BUY	$5.01 - $11.83 $971 - $2,295	194 Added 0.85%	23,059 $272,000
Q3 2022 Nov 16, 2022	BUY	$4.57 - $8.4 $103,282 - $189,840	22,600 Added 8528.3%	22,865 $135,000
Q2 2022 Aug 23, 2022	SELL	$3.74 - $10.66 $770 - $2,195	-206 Reduced 43.74%	265 $1,000
Q2 2022 Aug 16, 2022	BUY	$3.74 - $10.66 $220 - $628	59 Added 14.32%	471 $2,000
Q1 2022 May 16, 2022	BUY	$7.81 - $20.45 $2,436 - $6,380	312 Added 312.0%	412 $4,000
Q4 2021 Feb 14, 2022	SELL	$15.2 - $35.51 $167 - $390	-11 Reduced 9.91%	100 $2,000
Q3 2021 Nov 16, 2021	SELL	$21.78 - $40.45 $174 - $323	-8 Reduced 6.72%	111 $4,000
Q2 2021 Aug 16, 2021	SELL	$32.5 - $48.96 $195 - $293	-6 Reduced 4.8%	119 $5,000
Q1 2021 May 17, 2021	SELL	$41.61 - $54.3 $31,623 - $41,268	-760 Reduced 85.88%	125 $6,000
Q4 2020 Feb 16, 2021	SELL	$25.27 - $54.9 $1,263 - $2,745	-50 Reduced 5.35%	885 $46,000
Q3 2020 Nov 17, 2020	BUY	$18.49 - $27.24 $3,697 - $5,448	200 Added 27.21%	935 $25,000
Q2 2020 Aug 14, 2020	BUY	$8.9 - $21.84 $6,541 - $16,052	735 New	735 $15,000
Q4 2019 Feb 14, 2020	SELL	$5.1 - $11.2 $3,060 - $6,720	-600 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$4.02 - $8.04 $2,411 - $4,823	600 New	600 $5,000

Others Institutions Holding TGTX

# of Institutions

338

Shares Held

87.7M

Call Options Held

2.35M

Put Options Held

1.7M

View Full List

About TG THERAPEUTICS, INC.

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $4.69B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

More about TGTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.

Account

Captrust Financial Advisors Tg Therapeutics, Inc. Transaction History